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1. Introduction  
The most difficult to examine segment of the digestive tract is the small bowel. However, 
examining the distal portions that follow the duodeno-jejunal junction is vital when trying 
to diagnose an important number of pathologies, most of them with vital implications for 
the patient. 
Until recently, standard diagnostic techniques were limited to radiological barium-enhanced 
investigations, “push-enteroscopy” and intraoperatory enteroscopy, selective arteriography, 
scintigraphy or computer tomography. All these methods were either too intrusive, such as 
the case with intraoperatory enteroscopy, or did not provide sufficient data for an accurate 
diagnostic.  
Technological progresses in recent years allowed for the rapid development of novel, more 
patient-friendly and diagnostically competent investigation techniques dedicated to this 
particular GI segment. 
Videocapsule endoscopies (VCE), along with balloon (single or double) enteroscopy are 
currently considered the two most valuable tools available to the gastroenterologist. (Iddan 
et al, 2000; Swain P, 2003) 
The VCE system is currently the most widespread investigation technique for the small 
bowel, due to its convenience of use and slightly better affordability. It has been tested in a 
large number of studies, being compared to all other investigatory techniques, currently a 
large number of high-impact papers existing on the subject. It is estimated that over one 
million such devices have been swallowed over the course of almost ten years since its first 
introduction on a global scale.  
2. Historical background  
A miniaturized device, small enough for a human to swallow, that could reach all segments 
of the digestive tracts was imagined thirty years ago, in 1981, by Gavriel Iddan (considered 
the inventor of capsule endoscopy). He was the first to conceive a miniature wireless 
camera-enabled device that could reach the difficult segments of the digestive tract, 
otherwise accessible at that time only by means of small-bowel follow-through (SBFT). The 
technology of that time did not however permit for such miniaturized devices which could 
complete this task; hence, production was stopped for nearly 20 years. In 1994, he filled a 
patent for such a small wireless device equipped with a videocamera and capable of 
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transiting the gastrointestinal tract, while similar results being reported by Gong and Swain 
in the same year (Gong Fet al, 1994) and in 1996 (Swain C et al, 1996). 
The initial blueprint of the system remained mostly unchanged since conception, and 
consists of three main elements: a small, swallowable device equipped with a lens system, a 
recording sensor, an integrated circuit and a wireless antenna; a recording device equipped 
with skin-mounted sensors that receives and stores the video data, and a computer interface 
equipped with a specialized software application, necessary for later interpretation of these 
recordings. (Jeremy G et al, 2007; Koulaouzidis A et al, 2009) 
The technology progressed rapidly over the following years, and after almost 20 years since 
the first time that the idea emerged, the first prototype was produced by Given Imaging of 
Yokneam, Israel, in 1999. The device received FDA (U.S. Food and Drug Administration) 
approval in 2001, being the first such device to receive official accreditation for human use. 
This was the birth of the first videocapsule endoscopy system (VCE for short), and was 
entitled Pillcam® M2A. A series of more specialized devices for different anatomical regions 
were later introduces, such as the Pillcam® ESO (for the esophagus) and Pillcam® COLON, 
which is currently used in Europe and Israel. A specialized capsule for investigating the 
small bowel (entitled Pillcam® SB) followed the more general-use device M2A, and the ESO 
and Colon devices already received a generation update.  
Other VCE platforms became available, such as the one produced by Olympus Medical 
Systems Corp, Japan, the Chinese company Chongqing Jinshan Science and Technology, 
and the Korean company IntroMedic.  
Currently, the main differences between these platforms consist in different sensor types 
used for video recording, battery operating time and the complexity and features of the 
interpretation software. 
3. Technical characteristics 
As we noted earlier, technical constrains delayed the production of VCE systems. 
Complementary metal oxide semiconductor (CMOS) imaging sensors, small and affordable in 
price, became available in the late 1990s, the introduction of application-specific integrated 
circuits (ASIC) chips allowed for rapid data integration. Light emitting diode (LED) light 
sources became widespread, and all these components made good use of a small enough 
battery that could be integrated in the pill-shaped concept a videocapsule required. Recording 
devices could be smaller and lighter, larger capacity magnetic hard drives allowed for 
extensive storage space necessary for the several hours of recording time, and personal 
computing sufficiently evolved, allowing the production of software capable of displaying and 
analyzing the video files resulting from VCE recordings. (Vere CC et al, 2008) 
The videocapsule itself is basically an ingestible cylindrical device measuring 26x11 mm and 
weighting 3.7 grams. The on-board CMOS sensor captures two images per second. The 
device also contains an optical system, a LED light source, an ASIC control chip, a RFID 
antenna system, all these circuits being powered by a battery pack with a median lifespan of 
approximately 8 hours, which is considered to be the average duration of a full GI transit. 
The resulting video contains well over 50 000 images for one test. Recent generations 
improved the lightning capabilities of the LED system, with advanced light controls, as well 
as a wider lens system, offering 156° viewing angles (versus only 140° in the old systems. 
The improved optics also provides 1:8 magnifications and an estimated 1-30 mm depth of 
view. 
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Fig. 1. (a) – Videocapsule. The transparent optical dome hosts the camera lens system  
and the six LEDs used for illumination. The battery pack, circuit board and 
communication antenna are protected inside the body. (b) – Videocapsule in its original 
plastic container. Once removed, the capsule activates and starts sending images to the 
recording device. 
The Olympus version, the EndoCapsule for the small bowel, is equipped with a CCD 
(Charge Coupled Device) sensor for image acquisition. Its dimensions are basically the same 
(26x11 mm), weighting 3.8 grams and having a field of view of 145°, while providing a 
similar battery life of 8 hours. The EndoCapsule received clinical approval in the United 
States, parts of Europe and Japan. 
MiroCam®, the device produced by the Korean company Intromedic, records three frames 
per second (compared to only two frames on other devices), using a high resolution 
(320x320 pixels) CCD  image sensor, and has an improved battery pack capable of 
sustaining 11 hours of recording. The battery life is also improved by the different 
transmission method, which uses the human body as a conductive medium for sending data 
to the attached electrodes. The higher battery life, as well as different transmission method, 
may allow for a type of „second-look” enteroscopy to be performed by consecutively 
ingesting the two VCE systems. A recent pilot study however did not provide statistically 
significant data in this respect. (Kim HM et al, 2010) 
This system is not widely spread and clinical data is scarce on the actual upgrades in terms 
of patient management, although the extended recording time might make it more suitable 
for localizing distal lesions, which might be missed by other VCE systems due to incomplete 
examinations caused by lower battery life or patient-related factors such as higher transit 
times or longer GI tracts. 
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Fig. 2. The videocapsule in detail. 
Both the CMOS and the CCD imaging sensor offer excellent picture quality of the GI tract. 
While the CCD does produce the highest level of signal with the least amount of signal 
noise, the CMOS images get more uniform illumination at theoretical higher frame rates, 
due to the decreased size and dedicated ASIC imager chips enabled with power 
management algorithms and dynamic light and exposure adjustments. 
The second part of the wireless endoscopic capsule platform is represented by the lightweight 
data recorder unit, attached to the patients’ body by a belt, designed not only to support it, but 
also to attenuate radio signal loss. This receiver is equipped with a set of eight external 
adhesive electrodes that are placed on the lower chest and abdomen in precise locations. These 
serve as receivers for the radio frequency communication coming from the wireless capsule, 
while the recording unit itself, equipped with a magnetic disk drive and an appropriate 
hardware interface receives the signals, processes and stores them as image clips. The recorder 
has a rechargeable battery pack that ensures eight to ten hours of continuous functioning.  
 
 
Fig. 3. Recording unit with the receiving electrodes. The videocapsule itself, as well as the 
initial cradle are pictured above. 
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It is possible to review the live recording coming from the wireless videocapsule using an 
USB-connected viewing device equipped with a small LCD screen. It is also possible to 
approximate the capsule location by using a triangulation method that takes into account 
the receiving electrode, knowing that the capsule itself should be in the immediate vicinity 
of the active pad. This is extremely important, as prokinetics can be administered to ensure 
faster passage of the videocapsule through the pylorus, thus reducing the possibility of an 
incomplete enteroscopies due to gastric retention. (Qureshi Wa et al, 2005; Souquet JC et al, 
2005) 
It is notable that the MiroCam system developed in Korea uses a different system to 
transmit data, which, as noted above, improves battery performance of the video capsule, as 
well as making the use of both systems in parallel possible. (Delvaux M et al, 2008) 
Initially, protocols for capsule endoscopy excluded its use in patients with cardiac 
pacemakers, implantable defibrillators or other vital medical equipment, due to possible 
interference between the wireless capsule and these devices. As a large number of cardiac 
pacemakers and implantable defibrillators are available on the market today, it is practically 
impossible to test every single one, hence caution is always advised when dealing with this 
type of patients. Even though the majority of hospital protocols still enforce this regulation, 
several recent trials provided conclusive evidence that no significant interference actually 
occurs. Several reports cite blank periods when the receiving electrode was the one near the 
location of the patient’s pacemaker, lasting from 20 to 30 minutes.  This problem was 
resolved by adjusting the position of the electrode in relation to the pacemaking unit. 
(Gravina AG et al, 2010) No malfunctioning of the pacemaking units were recorded in the 
case report presented by Gravina et al, as well as several other studies.  (Gravina A.G et al 
2010; Guyomar Y. et al, 2004; Leighton J. A. et al, 2004; Payeras G et al, 2005;  Dirks M. H. et 
al, 2008; Bandorski D. et al, 2008; Daas AY et al, 2008) 
The reader station consists of a base unit that is connected to a workstation computer, 
equipped with specialized software that can receive and display in a specific user interface 
the recordings. The software installed on this computer receives each image recorded by CE 
and assembles a movie, in a proprietary format specific to each manufacturer that can only 
be read by its designed software equipment. Each recording device uses different 
compression algorithms; however the end result is a series of uncompressed images that can 
be fully exploited by the analyzer. The workstation software also applies various algorithms 
for image enhancement and land marking, later used by the examiner in reviewing a 
recording. Movies are usually stored on Data Versatile Disks (DVDs) or even high capacity 
universal-serial bus (USB) magnetic drives. Flash memory keys are usually used to transfer 
the data between the workstation and any computer or laptop which has the viewing 
software installed. 
The viewing software is one of the most updated components of the WCE platform, 
suffering continuous upgrades that come to help the physician in interpreting the CE 
recordings and reducing viewing time.  (Jeremy et al, 2007) 
It is possible to scroll faster or choose the exact moment from which to begin viewing, as 
with any recorded video material. The visual time bar also contains a color-grading 
component which can be used by the reviewer to distinguish between each type of mucosa, 
pertinent to one particular GI segment. All software programs also have the ability to extract 
single images from a video, or cut and edit video segments. The viewing speed may vary 
from 5-40 to up to 80 frames per second, depending on the viewed segment and the 
physician’s experience with CE recordings. Usual reviewing frame rates are between 12 and 
24 frames per second for small bowel investigations. (Gay G et al, 2006) 
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Fig. 4. Videocapsule software interface. 
It is also possible to view thumbnail previews of interest areas of the GI tract, giving the 
examining physician an overview, while cutting down on viewing time. Features such as the 
QuickView function, provided by both the Given and the Olympus software, or similar 
tools, are designed to reduce reading time, however are associated with greater diagnostic 
bias, hence being recommended only when Inflammatory bowel disease (IBD) is suspected, 
or prior to a full examination, for previewing purposes. (Westerhof J et al, 2009)  
Other useful additions to the viewing software are represented by the inclusion of the Fiji 
intelligent color enhancement (FICE) system, an inflammation (Lewis) scoring system, as 
well as a reference atlas to come to the aid of the interpreter.(Eliakim R et al, 2010)   
As a whole recording may take up to eight hours hence all software provided by companies 
producing CE systems offer a wide variety of specialized tools that help eliminating human 
error, as well as making the interest areas easier to spot. One such tool is the red color 
detection component, which highlights the images containing traces of red color, thus 
pinpointing the location of possible OGIBs, telangiectasia etc. According to some studies this 
function gives a high rate of false positives; however it remains extremely useful in 
detecting intestinal bleedings. (Signorelli C et al, 2005; D’Halluin PN et al, 2005) 
The time spent analyzing the video recordings varies from one to three-four hours, 
depending on the experience of the clinician, as well as the suspected pathology. Generally, 
viewing time for the small bowel varies between one and two hours. Many factors related to 
the existing conditions in the examining room may influence the interpretation of these 
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results, such as viewers’ distance from the computer screen, position and number of light 
sources, as well as factors linked to the examiner, such as reading speed, attention level and 
level of specialized training. Several studies compared reading abilities of specialized 
gastroenterologists versus trained physicians as well as gastroenterology nurses. (Reena S et 
al, 2007; Hoeroldt B.S. et al, 2008) The general consensus was that interpretation of these 
recordings does not pose extreme difficulties to any examiner, however, specialized training 
should be considered for all individuals performing this task. (Cave DR, 2004) 
Internet-based reading services currently exist, where several institutes provide on-line help 
with the analysis of the recordings, through a web-based interface. Specialized teams of 
physicians offer their experience, thus reducing the risk of overviewing essential diagnostic 
signs in an investigation. 
4. Examining technique 
4.1 Patient consent 
Even though it is a minimal invasive procedure, CE requires prior informed consent given 
by the patient. The performing physician has to fully explain the procedure, all risks 
deriving from it, as well as stating all potential complications, such as capsule retention, 
inconclusive findings or capsule aspiration. It should be noted that magnetic resonance 
imaging (MRI) is an absolute contraindication until the capsule passed the GI tract and its 
exit is confirmed. (Rondonotti E et al, 2005; Koulaouzidis A et al, 2009) The existence of 
cardiac pacemakers or implanted defibrillators may represent contraindications for capsule 
use, however, as noted earlier, recent consensus policies and a number of studies, confirm 
that the functioning of these devices is not influenced by CE. Caution is however advised, as 
a high number of different devices exist and not all have been tested. 
4.2 Bowel preparation 
According to existing literature, there is no standard bowel preparation for CE examining. 
(Melmed Gy et al, 2005) All patients are required to fast 10-12 hours prior to the 
investigation, and specific medication, such as iron tablets, opiates, and antimony drugs 
should be stopped two-three days prior to the investigation. 
Some studies recommend the use of prokinetic solutions which should accelerate intestinal 
transit, while claiming to improve image clarity and diagnostic accuracy. (Viazis N et al, 2004; 
Mylonaki M et al, 2003) when compared to clear liquids alone. (Niv Y et al, 2004; Cave D et al, 
2004; Ning D et al, 2005) However, a number of recent studies and meta-analyses concluded 
that bowel preparation is not necessary, as it does not improve the image quality or diagnostic 
rate of CE investigations. This conclusion is also supported by the latest consensus reports (de 
Franchis R et al, 2005) as well as by official recommendations given by several major capsule-
producing companies. The polyethylene glycol (PEG) electrolyte purgative solution is widely 
used for bowel preparation, as it was proven to improve the rate of complete procedures, 
(Triantafyllou K et al, 2010; Rokkas T et al, 2009) along with prokinetics (metoclopramid, 
domperidone or tegaserod), while not significantly influencing the quality of the results in 
small bowel investigations. The majority of UK clinics do not use prokinetics in daily practice. 
(Lapalus MG et al, 2008; Ben-Soussan E et al, 2005; Postgate A et al, 2009) 
4.3 Steps of the procedure 
Electrodes are placed with the patient in supine position on a bed or a bench, except obese 
patients on which they can be placed while standing. The recording device should have the 
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battery fully charged and all necessary connections with the sensor array properly 
established; afterwards the device is attached using the belt. 
The capsule is activated automatically once it is removed from its containing blister, after 
making sure that the expiration date is not overdue. The patient swallows the camera pill 
and the receiver starts recording as soon as it receives the first signal from the capsule.  
In cases when swallowing difficulties may interfere with the procedure, or when the device 
has failed to enter the small bowel despite prokinetic preparations, an endoscope equipped 
with a Roth® net or a special delivery device such as the AdvanCE® may be used. 
Once the capsule reached the small intestine, patients are free to move around, or in some 
cases even leave the hospital for a few hours. 
4.4 Capsule retention and the patency capsule 
One major concern when using CE is capsule retention at any level of the gastrointestinal 
(GI) tract. Besides the major cause of retention, obstruction, which also constitutes a major 
contraindication of this procedure, these situations can occur in stricturing Crohn’s disease 
patients, or in some obscure/occult GI bleedings (OGIBs).  
This problem can be prevented by using standard radiology and/or a special patency 
capsule, such as the Agile® patency capsule developed by Given Imaging. The patency 
system received a recent update. The second generation device now used consists of a 
central 13 x 3 mm radiofrequency identifiable tag (RFID), an antenna system and a magnet. 
A battery is not necessary for operating the device. It can receive electromagnetic waves at a 
frequency of 128 KHz, while emitting at 64 KHz. It also contains a small barium pellet which 
makes it trackable under a fluoroscopic screen. The device is placed in a lactose shell which 
completely dissolves once inside the GI tract and a plastic coating protects the device from 
digestive fluids. Excretion can be confirmed by X-ray examination or through the portable 
scanner which detects the electromagnetic signal it emits. If the patency capsule is excreted 
in under 30 hours of ingestion, the patient is viable for CE investigation. 
5. Indications and contraindications for Capsule Endoscopy 
The current list of indications for the VCE include a number of different pathologies, being 
somewhat limited by concomitant conditions which may be found in particular patients. 
As such, possible indications include, but are not restricted to: 
 Obscure, occult or manifest gastrointestinal bleedings with negative 
endoscopy/colonoscopy results; 
 Feriprive anemia of unknown cause; 
 Suspected small bowel Crohn’s disease; 
 Early evaluation of small bowel Crohn’s disease recurrence after surgical treatment; 
 Differential diagnosis of undetermined colitis; 
 Refractory or recurrent celiac disease despite treatment; Selected cases of intestinal 
malabosrbition with inconclusive conventional test results; 
 Complications of non-steroidal anti-inflammatory drug treatment; 
 Screening and surveillance of polyps in familial polyposis syndromes;  
 Suspected tumors of the small bowel;  
 Gastrointestinal „graft versus host” symptoms with GI interest; 
 Small bowel transplant; 
Several contraindications are cited in literature, some of them being relative while other 
clearly excluding the use of the device. 
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 Swallowing disorders (relative contraindication, as the capsule can be inserted with 
devices cited above); 
 Patients with implanted defibrillators/cardiac pacemakers, or who are to be subjected 
to RMI investigations before capsule passage completion (relative contraindication, as 
noted above); 
 Pregnant patients (tolerance insufficiencies); 
 Altered peristalsis (diabetic gastro paresis); 
 Gastrointestinal fistula; 
 Previous major surgical interventions in the abdominal/pelvic areas; 
 Suspicion of stenosis which could lead to capsule retention. 
6. Diagnostic yield, comparison with other investigations, and impact on 
clinical outcome 
A large number of studies exist on the diagnostic capabilities of this technology. The 
diagnostic yield of capsule endoscopy varies depending on the number of patients included 
in these studies, and several meta-analyses deal with the impact it has on disease 
progression and outcome. (Pennazio M et al, 2004; Appleyard MN et al, 2006; Gupta R et al, 
2006; Ersoy O et al, 2006; Lewis BS et al, 2002; Appleyard M et al, 2001; Rastogi A et al, 2004) 
The indications for CE investigations are somewhat limited, and insufficient evidence 
currently prevents its use on a larger scale (table 1) 
 
Indication 
Evidence 
Level
Grade of 
recommendation 
Obscure gastrointestinal bleeding
VCE may be used as the first investigation for OGIB after 
negative endoscopies (upper and lower)
2b B 
Recommended in patients with unexplained iron-deficiency 
anemia 
2b B 
Crohn’s disease 
Most indicated procedure for evaluation of small-bowel mucosal 
lesions specific to Crohn’s disease
3a B 
Small bowel imaging or patency capsules should be used to 
eliminate the risk of capsule retention in Crohn’s Disease
2b B 
NSAIDs treatment should be stopped two months prior to CE 2a B 
Celiac disease 
High diagnostic yield in Celiac disease patients 2b B 
Refractory or complicated celiac disease patients should receive 
CE 
2b B 
Small bowel tumors / Polyposis
Should be considered as first line of screening in patients with 
Peutz-Jeghers syndrome
2b B 
CE indicated in familial adenomatous polyps patients with 
duodenal polyps 
2b B 
Influenced the therapeutic work-up of small-bowel tumors 3b B 
Table 1. The 2009 European Society of Gastrointestinal Endoscopy (ESGE) updated 
information on the indications for video capsule endoscopy  (adapted from Ladas SD et al, 
2009) 
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6.1 Capsule endoscopy in obscure gastrointestinal bleedings 
Subgroup analysis showed that if patients suffer from ongoing GI bleedings, the diagnostic 
yield reaches as high as 92.3%, however it sharply descends to 44.2% in obscure occult 
bleedings. (Gupta R & Reddy DN, 2007) 
The International Consensus on Capsule endoscopy (2005 and 2006) recommend that the 
procedure should be performed within the first two weeks following patient admission 
(Pennazio M et al, 2005), as it has been proven that early use dramatically increases the 
chances of discovery of OGIBs. (Bresci G et al, 2005) Figure XX presents the suggested 
diagnostic algorithm for OGIBs, which recommends early use of CE after negative upper 
and lower endoscopy findings. 
 
 
Fig. 5. Proposed algorithm for the diagnosis and management of OGIBs. ICCE Consensus 
for obscure gastrointestinal bleedings, 2005 
The large majority of studies discuss the changes in patient management after capsule 
investigation, however failing to provide accurate information on the clinical outcome. In 
the case of OGIBs, a positive outcome is represented by successfully identifying the cause of 
bleeding and efficiently stopping it while preventing recurrences. Compean et al (2007) 
referred to 40 patient patients with chronic OGIB investigated by CE between 2003 and 2005. 
They assessed the impact of therapeutic interventions on the recurrence of OGIBs, following 
positive CE findings. The study found a positive correlation between the success rate of CE 
and favorable clinical outcome, recurrent bleedings being less likely in these patients. 
Pennazio et al (2004) followed a group of 56 patients over the course of 18 months, 
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determining that 85.9% of the patients with ongoing overt GI bleedings had complete 
resolution, compared with only 69.2% of the patients with current OGIBs and 41.4% of 
patients with prior episodes of OGIBs. Its conclusion was that a direct correlation between 
the time when CE is performed and the status of the GI bleeding exists, and is extremely 
important when assessing clinical outcome. 
A series of large multicentric studies reported changes in the management of OGIB patients 
after capsule endoscopy. Albert et al (2005) reported that 66% of a total of 247 included 
patients were recommended a certain procedure or followed a specific treatment after 
positive diagnostic by using CE. Other studies report that nearly 70% of all positively-
identified patients received adequate treatment. Contradictory results were reported 
however by Rastogi et al (2004), with positive clinical outcome in only 16% of all patients 
considered in their study. Positive and negative predictive values (PPV and NPV) of CE 
were reported to be extremely high in various studies. Delvaux and his team (2004) after a 
one-year follow-up of 44 patients, found a 94.% PPV and 100% NPV in CE patients. In his 
study of 100 consecutive cases, Pennazio et al (2004) reported a PPV of 97%, and 82.6% NPV. 
A large retrospective study performed in the Mayo Clinic proved that there was a 
significant decrease in hospitalization time for all OGIB patients after CE was performed. 
Also, it was noted that less investigations were performed, and that transfusional needs 
were reduced after positive CE investigations. 
Each study included variable population groups and lacked standardized management 
specific to different medical centers. This accounts for the relatively variable outcome and 
different diagnostic yields reported. (Lai LH et al, 2006; Carey EJ et al, 2007) More meta-
analyses and large populational studies are needed in order to give a final verdict on the 
efficacy of this method; however it is clear that both clinical outcome and disease 
management is influenced by CE in a positive manner. 
High diagnostic yield and ease of use make it a prime candidate in early diagnosis and 
screening programs for OGIBs. 
Since its introduction in 2000, the main concern with capsule endoscopy was to determine 
the advantages it provides over other more invasive existing techniques. 
The vast majority of published literature compared CE to PE, DBE and barium follow-
through. Wireless capsule performed better than radiation techniques and surpassed PE in 
diagnostic capabilities. Costamagna (Costamagna G et al, 2002) and Eliakim (Eliakim R et al, 
2003) reported more than 100% increase in positive findings when using CE after classical 
radiology. One meta-analysis (Leighton JA et al, 2006) totalizing 88 patients found a 59% 
increase in positive findings (67% positive CE versus only 8% barium investigations). 
Comparison with PE favors the use of CE, as the vast majority of studies indicate more than 
double diagnostic rates for capsule investigations (Saurin JC et al, 2003; Lewis BS et al, 2002; 
Ell C et al, 2002; Mylonaki M et al, 2003; Adler DG et al, 2004; Mata A et al, 2004; Hartmann 
D et al, 2003; Van Gossum A et al, 2003; Ge ZZ et al, 2004), especially when studies deal with 
occult OGIBs (Neu B et al, 2005) An analysis of these reports prompt a 63% yield for CE 
versus only 24% yield for PE. Another meta-analysis including 14 different studies 
(Leighton JA et al, 2006) and 396 patients revealed similar results, 63% positive results for 
CE and only 28% for PE. Small population groups, eligibility criteria and biases in the 
selection criteria were the main issues which could influence these statistics. 
In a study published in 2007, Saperas E et al showed that CE diagnostic yield was  
72%, compared with CT angiography (24%) or standard angiography (56%), also giving 
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more than double positive results when compared with standard CT scans. (Saperas E et al, 
2007) 
 
 
Fig. 6. Telangiectasies. Still images from different patients investigated with CE.  (from the 
Research Center of Gastroenterology and Hepatology of Craiova Videocapsule Endoscopy 
Image Archive). 
Recent studies focused on balloon enteroscopy, mainly the double balloon version, as it 
became increasingly popular over the world. CE has a higher detection rate of potential 
bleeding sources in a number of studies, mainly due to more complete investigations when 
compared with DBE. (Mehdizadeh S et al, 2006; Hadithi M et al, 2006) Hatidi et al (2006) 
performed both procedures on a lot of 35 patients, concluding that CE is more likely to 
detect the presence of bleedings; however the two procedures should be regarded as 
complementary rather than competitive.  
General consensus today is that early diagnosis by CE can be followed by DBE findings, 
combined with interventional enteroscopy by the same method. (Kameda N et al, 2008; 
Marmo R et al, 2007) 
6.2 Capsule endoscopy in Crohn’s disease 
In Crohn’s disease, patients often experience pain, diarrhea and weight loss, non-specific 
symptoms that do not correlate with the negative results from usual imaging investigations. 
(Kornbluth A et al, 2005) A consensus panel suggested that further investigation by CE is 
useful when patients display at least two of these symptoms. (Kornbluth A et al, 2005) 
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Fig. 7. Proposed algorithm for the diagnosis and management of Crohn’s disease by using 
CE and DBE. Adapted from Sidhu R et al, 2008. 
Capsule endoscopy has been shown to have a rather high diagnostic yield in non-stricturing 
Crohn’s disease. CE might prove useful in both diagnosing early the disease, as well as in 
establishing disease prognostic, activity or mucosal response to treatment. Triester et al 
(2006) concluded in their meta-analysis that CE does not differ in diagnostic yield from 
other investigations when an initial suspicion of Crohn’s disease existed. A statistically 
significant difference, favoring CE, existed however when analyzing subgroups of patients 
with established disease and suspected small-bowel recurrence. A small prospective study 
on only 27 patients having a suspected diagnosis of Crohn’s disease shown a sensitivity of 
93% and specificity of 84% for CE, also demonstrating significant changes in their 
management and subsequent outcome. (Girelli CM et al, 2007) A recent study shown that 
CE is useful in patients displaying atypical clinical symptoms, especially when surgery was 
performed at some point. (Mehdizadeh S et al, 2008) However, not all studies published so 
far rate CE as the most effective method of investigating Crohn’s disease. A retention rate as 
high as 5 to 13 percent in Crohn’s disease patients (Cheifetz AS et al, 2006) encourage the 
use of small-bowel follow-through, CT or a patency capsule examination prior to capsule 
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ingestion. This was shown to limit the use as a first-intent test in a small prospective study. 
(Solem CA et al, 2008) When investigating disease recurrence after surgery, CE proved to be 
more useful than colonoscopy and ileal intubation. Recurrence was demonstrated in 15 out 
of 24 patients after CE, compared to only 6 after colonoscopy (62% versus 25%).  (Pons B et 
al, 2007) 
A diagnostic index with a scoring system designed for grading disease activity in the small 
bowel, destined for clinical needs and research, was recently developed, as nonsteroidal 
anti-inflammatory drug intake, lymphomas, vasculitis or infectious disease may resemble 
the lesions found in Crohn’s disease patients. (Gal E et al, 2008) 
A meta-analysis of multiple studies, totaling 115 patients, showed a diagnostic yield of 61% 
for CE, compared to only 46% for ileo-colonoscopy. (Kornbluth A et al, 2005).  Comparisons 
with push enteroscopy also favored the videocapsule, as this method allows deeper small 
bowel mucosa visualization. (Chong AK et al, 2005; Herrerias JM et al, 2003) Ileo-
colonoscopy has a higher yield in the detection of disease recurrence compared to CE in 
patients who underwent ileo-colonic resection (Sidhu et al, 2008); however, one study 
showed that even at lower sensitivity, CE positively identified lesions outside the reach of 
the ileo-colonoscope. (Bourreille A et al, 2006) 
Comparison with small bowel barium imaging showed superior diagnostic yield for CE, 
when dealing with suspected or recurrent Crohn’s disease. (Chong AK et al, 2005; Dubcenco 
E et al, 2005; Triester et al, 2005; Marmo R et al, 2005) Higher diagnostic yield of CE when 
compared with CT enteroclysis were reported, and comparisons between CE and MR 
enteroclysis showed comparable or better yield for CE. Capsule retention remains a risk in 
patients with Crohn’s disease, hence the majority of studies comparing radiological imaging 
techniques with CE clearly underline that the presence of strictures identified by said 
methods precluded further use of the videocapsule. A recent meta-analysis showed superior 
diagnostic yield to both barium follow-through and ileo-colonoscopy in non-stricturing 
Crohn’s disease patients. (Triester et al, 2006) 
Double balloon enteroscopy is considered the golden standard when assessing the 
diagnostic yield of CE, however studies with a longer follow-up period are required. The 
general consensus, as with most other indications, is that both procedures are beneficial and 
are not exclusive to each other.  
6.3 Capsule endoscopy in celiac disease 
Being a non-invasive investigation with a deep visualization of the intestine, CE may prove 
useful in the diagnosis of celiac disease. The mucosal “mosaic” pattern specific to celiac 
disease is recognized on the CE recording, and the usual aspects such as scalloping, loss of 
mucosal folds and mucosal atrophy are easily spotted. Also, positive correlation between 
aspects seen in endoscopy and those observed after CE evaluation, coupled with the greater 
reach of the latter, point to it as a useful tool for “virtual histology”, giving the possibility of 
a correct macroscopic interpretation of the mucosal lesions. 
In suspected celiac disease, when using duodenal histology as a gold standard, three studies 
shown good sensitivity (80%, 87.5% and 92%, respectively), as well as excellent specificity 
(100%, 90.9% and 100%, respectively) of the CE for a positive diagnosis.  (Hopper AD et al, 
2007; Rondonotti E et al, 2007; Murray JA et al, 2008) At present, however, more evidence is 
needed for CE to be used as a routine investigation in celiac disease, and duodenal biopsy 
remains the gold standard. (Sidhu R et al, 2008) 
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Patients with known celiac disease would also benefit from CE, as an evaluation of 
refractory or complicated forms is often needed. CE was shown to have a high diagnostic 
yield in identifying abnormalities of the mucosa and exclusion of adenocarcinomas. A study 
reported a yield of 60% in detection of complications relating to celiac disease, including 
ulcerated mucosa, malignancy and strictures (Culliford A et al, 2005)  
 
 
Fig. 8. Celiac disease. Still images from different patients investigated with CE. (from the 
Research Center of Gastroenterology and Hepatology of Craiova Videocapsule Endoscopy 
Image Archive) 
6.4 Capsule endoscopy in hereditary polyposis syndromes 
A number of studies indicate that CE has a superior diagnostic capability in identifying 
polyposis syndromes (both familial polyposis, and Peutz-Jeghers syndrome) when 
compared with small bowel barium follow-through and MRI. (Mata A et al, 2005) 
Detection rate was however influenced by the polyp size, as detection rate was equal for 
polyps larger than 15 mm, and greatly improved when sizes decreased, being visible only 
through CE when they were below 5 mm. However, CE provided incomplete data 
regarding large polyps, while MRI provided a better estimation of their site and size. 
(Caspari R et al, 2004) 
Recent data suggests that CE may be used as a replacement for enteroclysis for surveillance 
of Peutz-Heghers syndrome patients; however this is not accurate in all cases, as it has low 
sensitivity for identifying the major papilla, also being inaccurate in distinguishing between 
periampullar and ampullary regions. (Ladas et al, 2009) 
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Fig. 9. Intestinal polyps. Still images from different patients investigated with CE. (from the 
Research Center of Gastroenterology and Hepatology of Craiova Videocapsule Endoscopy 
Image Archive) 
6.5 Capsule endoscopy in diagnosing small-bowel tumors 
Older literature showed a discrepancy between the number of diagnosed small bowel 
tumors during the course of life, and post-mortem autopsy findings. This was mostly due to 
the lack of investigatory techniques for this portion of the intestinal tract. As such, after the 
introduction of CE in routine clinical practice, the reported incidence for small-bowel 
tumors raised from 2% to as high as 9.6% (Corbin et al, 2006; Urbain D et al, 2006; 
Rondonotti E et al, 2008) 
Capsule endoscopy is useful in diagnosing a full range of malignancies, the majority of 
findings being adenocarcinomas. Gastrointestinal stromal tumors are the most frequent 
benign tumoral finding, with more than 32% incidence (Rondonotti E et al, 2008) A complete 
list of usual tumors identified by CE can be found in table 2. 
The majority of tumors are found in the jejunum (approximately 60%), followed by ileum 
(25-40%) and the duodenum (15-20%).  
CE investigation is frequently delayed by multiple negative standard techniques, which do 
not provide sufficient data regarding the small bowel. It was shown that a good estimation 
of tumor location compared with surgical findings exists, thus dramatically influencing the 
course of the treatment and disease outcome. Accurate information regarding the location, 
dimensions and appearance is also available after CE. (Sidhu R et al, 2009) 
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Fig. 10. Intestinal tumor. Still images from different patients investigated with CE. (from the 
Research Center of Gastroenterology and Hepatology of Craiova Videocapsule Endoscopy 
Image Archive) 
 
Malignant tumors 
Adenocarcinomas 
Carcinoid tumors 
Lymphomas 
Sarcomas 
Hamartomas 
Benign tumors 
Gastrointestinal stromal tumors (GISTs) 
Inflammatory polyps 
Lymphangiomas 
Lymphangioectasias,  
Hemangiomas,  
Hamartomas, 
Adenomas, 
Lipomas 
Metastases 
Colonic adenocarcinomas 
Hepatocellular Carcinomas 
Table 2. Usual tumoral findings following Capsule Endoscopy. 
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7. Capsule endoscopy: Cost effectiveness 
Capsule endoscopy represents a viable diagnostic tool in the early detection of OGIBs. One 
of the primary advantages being the ease of use, when accounting for its similar or greater 
diagnostic yields, it becomes evident that the method may be cost-effective for both 
screening and for patient diagnostic. Oradei et al (2005) estimated the costs of CE treatment 
on a population of 76 OGIB patients by studying synthetic indicators of different diagnostic 
tests. The main conclusion was that CE is indicated when diagnosing small bowel 
pathology, especially when an active bleeding is present. Similar findings were reported by 
Dyer et al (2004) in an Australian hospital, this study also proving the superiority of this 
procedure when compared with series radiography (58% versus only 4%).  
As patients need no further diagnostic tests after a positive CE finding, do not necessarily 
require hospitalization, and there is no imperative need for bowel preparation, the 
procedure may be cost-effective when dealing with OGIB suspected subjects. (Marmo R et 
al, 2007; Oradei et al, 2005) 
DBE and CE are considered complementary, initial DBE proved to be more cost effective; 
however CE followed by DBE was more cost-effective if DBE showed a probability below 
59% of angiectasia. (Dyer S et al, 2004; Kamal A et al, 2006) 
8. Conclusion 
The videocapsule represents one of the most useful technologies for exploring an otherwise 
difficult segment of the digestive tracts. Its use on a larger scale in a clinical environment 
will help provide physicians take correct, informed decisions regarding a wide range of 
pathologies. A number of studies demonstrated multiple uses in screening, diagnostic or 
stadialization of different diseases. 
Future protocols will probably include the technology in even more therapeutic strategies, 
confirming its usefulness and unique abilities. Hospitalization costs will be reduced as 
technology advances, as patients will not require extensive care before and after the 
completion of the procedure. 
Despite the limitations and lack of treatment abilities, CE established itself as an accurate 
tool in the arsenal of endoscopic procedures available to an increasing number of clinicians 
around the globe. Different products offer a wide choice of features, even enabling 
concomitant use of two different devices to perhaps improve diagnostic accuracy, under 
special conditions.  
Different improvements are expected in the following years, most notably in the image 
capturing field, where new compact High-Definition image sensors are expected to 
drastically improve the level of detail in captured movies. The software used for analysis is 
under continuous development, new features aiding the clinicians in their task to detect 
abnormalities. Improved battery life-span and perhaps basic maneuverability inside the 
digestive tract should be available in future generations of the device, thus dramatically 
improving diagnostic accuracy and specificity. Drug-delivery mechanisms, small surgical 
tools and enhanced imagistic equipment are just some of the multiple future add-ons which 
are planned for future iterations, further expanding the list of uses for the device. 
In conclusion, Capsule Endoscopy currently provides a convenient alternative to more 
conventional or novel, but invasive techniques for exploring the small intestine. Future 
improvements of the platform, and virtually endless possibilities to improve upon the concept, 
will continue to offer even more benefits for the patients, at increasingly lower costs. 
www.intechopen.com
 Videocapsule Endoscopy of the Small Bowel 
 
143 
9. References 
Adler DG, Knipschield M, Gostout C. A prospective comparison of capsule endoscopy and 
push enteroscopy in patients with GI bleeding of obscure origin. Gastrointest Endosc 
2004;59:492–498. 
Albert J, Schulbe R, Hahn W. Therapeutic consequences of capsule endoscopy in obscure 
intestinal bleeding; a multicenter outcome study, in proceedings of the 4th International 
Conference on Capsule Endoscopy 2005; Miami, Florida, USA. 
Appleyard M, Glukhovsky A, Swain P. Wireless-capsule diagnostic endoscopy for recurrent 
small-bowel bleeding. N Engl J Med 2001; 344: 232-233. 
Appleyard MN, Walsh A. Capsule endoscopy for obscure gastro intestinal bleeding; a report 
of 100 consecutive cases and long term clinical outcome. Gastointest endosc 2006; 63 
Suppl: S154. 
Bandorski D., W. Irnich, M. Bruck, et al., Capsule endoscopy and cardiac pacemaker: 
Investigation for possible interference, Endoscopy, Vol. 40, pp. 36-39, 2008. 
Ben-Soussan E, Savoye G, Antonietti M, Ramirez S, Ducrotté P, Lerebours E. Is a 2-liter PEG 
preparation useful before capsule endoscopy? J Clin Gastroenterol. 2005;39:381–384.  
Bourreille A, Jarry M, D’Halluin PN, et al. Wireless capsule endoscopy versus ileocolonoscopy 
for the diagnosis of post-operative recurrence of Crohn’s disease: a prospective study. 
Gut 2006:55:978–83. 
Bresci G, Parisi G, Bertoni M, Tumino E, Capria A. The role of video capsule endoscopy for 
evaluating obscure gastrointestinal bleeding: usefulness of early use. J Gastroenterol 
2005; 40: 256-259. 
Carey EJ, Leighton JA, Heigh RI et al. A single-center experience of 260 consecutive patients 
undergoing capsule endoscopy for obscure gastrointestinal bleeding. Am J 
Gastroenterol 2007; 102: 89–95 
Caspari R, von Falkenhausen M, Krautmacher C et al. Comparison of capsule endoscopy and 
magnetic resonance imaging for the detection of polyps of the small intestine in 
patients with familial adenomatous polyposis or with Peutz–Jeghersʼ syndrome. 
Endoscopy 2004; 36: 1054–1059 
Cave D. Reading wireless video capsule endoscopy. Gastrointest Endosc Clin North Am 
2004;14:17–24  
Cheifetz AS, Korenbluth AA, Legnani P et al. The risk of retention of the capsule endoscope in 
patients with known or suspected Crohn’s disease. Am J Gastroenterol 2006; 101: 2218–
2222  
Chong AK, Taylor A, Miller A, et al. Capsule endoscopy vs. push enteroscopy and enteroclysis 
in suspected small-bowel Crohn’s disease. Gastrointest Endosc 2005;61:255–61. 
Compean et al. Impact of therapeutic interventions induced by capsule endoscopy on long 
term outcome in chronic obscure GI bleeding. Gastroenterol Clin Biol 2007;31:806-811. 
Cobrin GM, Pittman RH, Lewis BS. Increased diagnostic yield of small bowel tumors with 
capsule endoscopy. Cancer 2006; 107: 22–27 
Costamagna G, Shah SK, Riccioni ME, Foschia F, Mutignani M, Perri V, et al. A prospective 
trial comparing small bowel radiographs and video capsule endoscopy for suspected 
small bowel disease. Gastroenterology 2002;123(4):999-1005. 
Culliford A, Daly J, Diamond B, et al. The value of wireless capsule endoscopy in patients with 
complicated celiac disease. Gastrointest Endosc 2005;62:55–61. 
D’Halluin PN, Delvaux M, Lapalus MG, et al. Does the ‘‘Suspected Blood Indicator’’ improve 
the detection of bleeding lesions by capsule endoscopy? Gastrointest Endosc 
2005;61:243-9 
www.intechopen.com
 New Techniques in Gastrointestinal Endoscopy 
 
144 
Daas AY, Small MB, Pinkas H, Brady PG. Safety of conventional and wireless capsule 
endoscopy in patients supported with nonpulsatile axial flow Heart-Mate II left 
ventricular assist device. Gastrointest Endosc. 2008;68:379–382 
de Franchis R, Avgerinos A, Barkin J, Cave D, Filoche B; ICCE. ICCE consensus for bowel 
preparation and prokinetics. Endoscopy. 2005 Oct;37(10):1040-5] [Consensus Report on 
videocapsule endoscopy. 5th ICCE 2006 Miami Florida 
de Leusse A, Vahedi K, Edery J et al. Capsule endoscopy or push enteroscopy for first-line 
exploration of obscure gastrointestinal bleeding? Gastroenterology 2007; 132: 855–862 
Delvaux M, Fassler I, Gay G. Clinical usefulness of the endoscopic video capsule as the initial 
intestinal investigation in patients with obscure digestive bleeding: validation of a 
diagnostic strategy based on the patient outcome after 12 months. Endoscopy 
2004;36:1067–1073. 
Delvaux M, Gay G. Capsule endoscopy: technique and indications. Best Pract Res Clin 
Gastroenterol. 2008;22:813–837 
Dirks M. H., F. Costea, and E. G. Seidman, Successful videocapsule endoscopy in patients with 
an abdominal cardiac pacemaker, Endoscopy, Vol. 40, pp. 73-75, 2008.   
Dubcenco E, Jeejeebhoy KN, Petroniene R, et al. Capsule endoscopy findings in patients with 
established and suspected small-bowel Crohn’s disease: correlation with radiologic, 
endoscopic, and histologic findings. Gastrointest Endosc 2005;62:538–44. 
Dyer S, Standfield L, Tilden D, Mernagh P, Fitzgerald P. Assessment of the cost-effectiveness 
of M2A (TM) capsule endoscopy to inform public funding policy in Australia. Proc 
One HTA Health Technol Assess Int Meet 1st 2004 Krakow Pol. 2004; 1: 30. 
Eliakim R, Fischer D, Suissa A, Yassin K, Katz D, Guttman N, et al. Wireless capsule video 
endoscopy is a superior diagnostic tool in comparison to barium follow-through and 
computerized tomography in patients with suspected Crohn’s disease. Eur J 
Gastroenterol Hepatol 2003;15(4):363-7. 
Eliakim R. Video Capsule Endoscopy of the Small Bowel. Curr Opin Gastroenterol. 
2010;26(2):129-133 
Ell C, Remke S, May A, Helou L, Henrich R, Mayer G. The first prospective controlled trial 
comparing wireless capsule endoscopy with push enteroscopy in chronic 
gastrointestinal bleeding. Endoscopy 2002;34:685–689. 
Ersoy O, Sivri B, Arslan S, Batman F, Bayraktar Y. How much helpful is the capsule endoscopy 
for the diagnosis of small bowel lesions? World J Gastroenterol 2006; 12: 3906-3910. 
Fireman Z, Mahajna E, Broide E, et al. Diagnosing small bowel Crohn’s disease with wireless 
capsule endoscopy. Gut 2003; 52: 390-2.  
Gal E, Geller A, Fraser G et al. Assessment and validation of the new capsule endoscopy 
Crohn’s disease activity index. Dig Dis Sci 2008; 53: 1933–193 
Gay G, Delvaux M, Fassler I. Capsule endoscopy of the small bowel. Nancy (France): ALN 
Editions; 2006 
Ge ZZ, Hu YB, Xiao SD. Capsule endoscopy and push enteroscopy in the diagnosis of obscure 
gastrointestinal bleeding. Chin Med J (Engl) 2004;117:1045–1049. 
Ge ZZ, Hu YB, Xiao SD. Capsule endoscopy in diagnosis of small bowel Crohn’s disease. 
World J Gastroenterol 2004; 10: 1349–52. 
Gerber J, MSc, MPhil ARCS, Ari Bergwerk, MD, David Fleischer, MD A capsule endoscopy 
guide for the practicing clinician: technology and troubleshooting Gastrointestinal 
Endoscopy  2007; 66(6) : 1188-1195  
Girelli CM, Porta P, Malacrida V et al. Clinical outcome of patients examined by capsule 
endoscopy for suspected small bowel Crohn’s disease. Dig Liv Dis 2007; 39: 148–154 
www.intechopen.com
 Videocapsule Endoscopy of the Small Bowel 
 
145 
Gong F, Swain CP, Mills TN. An endorobot for gastrointestinal endoscopy. Gut 
1994;35(Suppl):52S 
Gravina, A.G.; Bozzi, R.; Romano, I.J.; Pezzullo, E.; Miranda, A.; Merola, M.G.; Romano, M.; 
Pezzull. Cardiac pacemaker and wireless capsule endoscopy interference: case report 
in a patient with gastric vascular ectasias. Wireless Sensor Network. Published: Mar 1, 
2010 
Gupta R, Lakhtakia S, Tandan M, Banerjee R, Ramchandani M, Anuradha S, Ramji C, Rao GV, 
Pradeep R, Reddy DN. Capsule endoscopy in obscure gastrointestinal bleeding--an 
Indian experience. Indian J Gastroenterol 2006; 25: 188-190. 
Gupta R, Reddy DN. Capsule endoscopy: Current status in obscure gastrointestinal bleeding. 
World J Gastroenterol 2007; 13(34): 4551-4553. 
Guyomar Y., L. Vandeville, S. Heuls, et al., Interference between pacemaker and video capsule 
endoscopy, Pacing and Clinical Electrophysiology, Vol. 27, pp. 1329-1330, 2004 
Hadithi M, Heine GD, Jacobs MA et al. A prospective study comparing video capsule 
endoscopy with double balloon enteroscopy in patients with obscure gastrointestinal 
bleeding. Am J Gastroenterol 2006; 101: 52–57 
Hartmann D, Schilling D, Bolz G, Hahne M, Jakobs R, Siegel E, Weickert U, Adamek HE, 
Riemann JF. Capsule endoscopy versus push enteroscopy in patients with occult 
gastrointestinal bleeding. Z Gastroenterol 2003;41:377–382. 
Hartmann D, Schmidt H, Bolz G et al. A prospective two-center study comparing wireless 
capsule endoscopy with intraoperative enteroscopy in patients with obscure GI 
bleeding. Gastrointest Endosc 2005; 61: 826–832 
Herrerias JM, Caunedo A, Rodriguez-Tellez M, et al. Capsule endoscopy in patients with 
suspected Crohn’s disease and negative endoscopy. Endoscopy 2003; 35: 564-8. 
Hoeroldt B.S., A.D. Hopper, M. Karmo, C. Salmon, D. Elphick, A. Ali, D.S. Sanders. Is formal 
training necessary for capsule endoscopy?: The largest gastroenterology trainee study 
with controls. Digestive and Liver Disease, 2008, 40(4): 298-302  
Hopper AD, Sidhu R, Hurlstone DP et al. Capsule endoscopy: an alternative to duodenal 
biopsy for the recognition of villous atrophy in coeliac disease? Dig Liv Dis 2007; 39: 
140–145 
Iddan G, Meron G, Glukhovsky A, Swain P. Wireless capsule endoscopy. Nature 2000;405:417 
Kamal A, Gerson LB. Jejunal diverticulosis diagnosed by double-balloon enteroscopy. 
Gastrointest Endosc 2006; 63: 864. 
Kamalaporn P, Cho S, Basset N et al. Double-balloon enteroscopy following capsule 
endoscopy in the management of obscure gastrointestinal bleeding: outcome of a 
combined approach. Can J Gastroenterol 2008; 22: 491–495 
Kameda N, Higuchi K, Shiba M et al. A prospective, single-blind trial comparing wireless 
capsule endoscopy and double-balloon enteroscopy in patients with obscure 
gastrointestinal bleeding. J Gastroenterol 2008; 43: 434–440 
Kim HM, YJ Kim, HJ Kim et al. A Pilot Study of Sequential Capsule Endoscopy Using 
MiroCam and PillCam SB Devices with Different Transmission Technologies. Gut and 
Liver, 2010, 4(2), 192-200 
Koulaouzidis A, Douglas S. Capsule endoscopy in clinical practice: concise up-to-date 
overview. Clinical and Experimental Gastroenterology 2009:2 111–116 
Koulaouzidis A, Pendlebury J, Douglas S, Plevris JN. Aspiration of video capsule; rare but 
potentially life threatening complication to include in your consent form. Am J 
Gastroenterol. 2009;104:1602–1603  
Kornbluth A, Colombel JF, Leighton JA, et al. ICCE Consensus for Inflammatory Bowel 
Disease. Endoscopy 2005;37:1051–4. 
www.intechopen.com
 New Techniques in Gastrointestinal Endoscopy 
 
146 
Ladas SD, Triantafyllou K, Spada C, Riccioni ME, Rey JF, Niv Y, Delvaux M, de FR, 
Costamagna G. European Society of Gastrointestinal Endoscopy (ESGE): 
recommendations (2009) on clinical use of video capsule endoscopy to investigate 
small-bowel, esophageal and colonic diseases. Endoscopy 2010; 42:220-227 
Lai LH, Wong GI, Chow DK et al. Long term follow-up of patients with obscure 
gastrointestinal bleeding after negative capsule endoscopy. Am J Gastroenterol 2006; 
101: 1224–1228 
Lapalus MG, Ben Soussan E, Saurin JC, et al; Société Française d’Endoscopie Digestive. 
Capsule endoscopy and bowel preparation with oral sodium phosphate: a 
prospective randomized controlled trial. Gastrointest Endosc. 2008;67:1091–1096.  
Leighton J. A., V. K. Sharma, K. Srivathsan, et al., "Safety of capsule endoscopy in patients with 
pacemakers," Gastrointestinal Endoscopy, Vol. 59, pp. 567, 2004. 
Leighton JA, Triester SL, Sharma VK. Capsule endoscopy: A meta-analysis for use with 
obscure gastrointestinal bleeding, and Crohn’s disease. Gastrointest Endosc 
2006;16:229-250. 
Lewis BS, Swain P. Capsule endoscopy in the evaluation of patients with suspected small 
intestinal bleeding: Results of a pilot study. Gastrointest Endosc 2002; 56: 349-353. 
Manning-Dimmitt LL, Dimmitt SG, Wilson GR. Diagnosis of gastrointestinal bleeding in 
adults. Am Fam Physician 2005; 71: 1339-46.  
Marmo R, Rotondano G, Piscopo R, et al. Capsule endoscopy versus enteroclysis in the 
detection of small-bowel involvement in Crohn’s disease: a prospective trial. Clin 
Gastroenterol Hepatol 2005;3:772–6. 
Marmo R, Rotondano G, Rondonotti E et al. Capsule enteroscopy vs other diagnostic 
procedures in diagnosing obscure gastrointestinal bleeding: a cost-effectiveness 
study. Eur J Gastroenterol Hepatol 2007; 19: 535–542 
Mata A, Bordas JM, Feu F, Gines A, Pellise M, Fernandez-Esparrach G, Balaguer F, Pique JM, 
Llach J. Wireless capsule endoscopy in patients with obscure gastrointestinal 
bleeding: a comparative study with push enteroscopy. Aliment Pharmacol Ther 
2004;20:189–194. 
Mata A, Llach J, Castells A et al. A prospective trial comparing wireless capsule endoscopy 
and barium contrast series for small-bowel surveillance in hereditary GI polyposis 
syndromes. Gastrointest Endosc 2005; 61: 721–725 
Mehdizadeh S, Ross A, Gerson L et al. What is the learning curve associated with double 
balloon enteroscopy? Technical details and early experience in 6 U.S. tertiary care 
centers. Gastrointest Endosc 2006; 64: 740–750  
Mehdizadeh S, Chen G, Enayati PJ et al. Diagnostic yield of capsule endoscopy in ulcerative 
colitis and inflammatory bowel disease of unspecific type. Endoscopy 2008; 40: 30–35 
Melmed Gil Y., Simon K. Lo.Capsule Endoscopy: Practical Applications. Clin Gastro and Hepato 
2005;3:411–422 
Murray JA, Rubio-Tapia A, VanDyke CT et al. Mucosal atrophy in celiac disease: extent of 
involvement, correlation with clinical presentation and response to treatment. Clin 
Gastroenterol Hepatol 2008; 6: 186– 193 
Mylonaki M, Fritscher-Ravens A, Swain P. Wireless capsule endoscopy: a comparison with 
push enteroscopy in patients with gastroscopy and colonoscopy negative 
gastrointestinal bleeding. Gut 2003;52:1122–1126 
Nakamura M, Niwa Y, Ohmiya N et al. Preliminary comparison of capsule endoscopy and 
double-balloon enteroscopy in patients with suspected small-bowel bleeding. 
Endoscopy 2006; 38: 59–66 
www.intechopen.com
 Videocapsule Endoscopy of the Small Bowel 
 
147 
Neu B, Ell C, May A, Schmid E, Riemann JF, Hagenmuller F, Keuchel M, Soehendra N, Seitz 
U, Meining A, Rosch T. Capsule endoscopy versus standard tests in influencing 
management of obscure digestive bleeding: results from a German multicenter trial. 
Am J Gastroenterol 2005;100:1736–1742. 
Ning Dai MD, Christoph Gubler MD, Peter Hengstler et al Improved capsule endoscopy after 
bowel preparation Gastoint Endosc. 2005; 61(1):28-31 
Niv Y, Niv G. Capsule endoscopy: role of bowel preparation in successful visualization. Scand 
J Gastroenterol 2004;39:1005–1009 
Oradei M, Calandriello M, Riccioni ME, Pirozzi GA, Costamagna G. Cost-effectiveness of 
video capsule endoscopy for diagnosis of suspected small bowel disease. Ital J Public 
Health. 2005; 2: 272. 
Payeras G., J. Piquersas, V. J. Morena, et al., Effects of capsule endoscopy on cardiac 
pacemakers, Endoscopy, Vol. 37, pp. 1181-1185, 2005.  
Pennazio M, Eisen G, Goldfarb N. ICCE consensus for obscure gastrointestinal bleeding. 
Endoscopy 2005; 37: 1046-1050. 
Pennazio M, Santucci R, Rondonotti E, Abbiati C, Beccari G, Rossini FP, De Franchis R. 
Outcome of patients with obscure gastrointestinal bleeding after capsule endoscopy: 
report of 100 consecutive cases. Gastroenterology 2004; 126: 643-653.  
Pons Beltran, V, Nos P, Bastida G et al. Evaluation of postsurgical recurrence in Crohn’s 
disease: a new indication for capsule endoscopy. Gastrointest Endosc 2007; 66: 533–
540 
Postgate A, Tekkis P, Patterson N, Fitzpatrick A, Bassett P, Fraser C. Are bowel purgatives and 
prokinetics useful for small bowel capsule endoscopy? A prospective randomized 
controlled study. Gastrointest Endosc. 2009;69(6):1120–1128  
Qureshi WA, Willingham F, Opekun A, et al. Localizing the lesion in capsule endoscopy: 
factors determining accuracy [abstract]. 4th International Conference on Capsule 
Endoscopy, March 7–8, 2005. Program and Abstracts. p. 151.  
Rastogi A, Schoen RE, Slivka A. Diagnostic yield and clinical outcomes of capsule endoscopy. 
Gastrointest Endosc 2004; 60: 959-964. 
Rokkas T, Papaxoinis K, Triantafyllou K, Pistiolas D, Ladas SD. Does purgative preparation 
influence the diagnostic yield of small bowel video capsule endoscopy? A 
metaanalysis. Am J Gastroenterol 2009; 104: 219-227 
Rondonotti E, Herrerias JM, Pennazio M, et al. Complications, limitations, and failures of 
capsule endoscopy: a review of 733 cases. Gastrointest Endosc. 2005;62:712–716.  
Rondonotti E, Spada C, Cave D et al. Video capsule enteroscopy in the diagnosis of celiac 
disease: a multicenter study. Am J Gastroenterol 2007; 102: 1624–1631 
Rondonotti E, Pennazio M, Toth E et al. Small-bowel neoplasms in patients undergoing video 
capsule endoscopy: a multicenter European study. Endoscopy 2008; 40: 488–495 
Saperas E, Dot J, Videla S et al. Capsule endoscopy versus computed tomographic or standard 
angiography for the diagnosis of obscure gastrointestinal bleeding. Am J Gastroenterol 
2007; 102: 731–737 
Saperas E, Dot J, Videla S et al. Capsule endoscopy versus computed tomographic or standard 
angiography for the diagnosis of obscure gastrointestinal bleeding. Am J Gastroenterol 
2007; 102: 731–737. 
Saurin JC, Delvaux M, Gaudin JL, Fassler I, Villarejo J, Vahedi K, Bitoun A, Canard JM, 
Souquet JC, Ponchon T, Florent C, Gay G. Diagnostic value of endoscopic capsule in 
patients with obscure digestive bleeding: blinded comparison with video push-
enteroscopy. Endoscopy 2003;35:576–584. 
www.intechopen.com
 New Techniques in Gastrointestinal Endoscopy 
 
148 
Sidhu, Reena MRCP; Sanders, David S. MD, FRCP, FACG; Kapur, Kapil FRCP; Marshall, 
Laura RGN; Hurlstone, David P. MD, MRCP; McAlindon, Mark E. Capsule 
Endoscopy: Is There a Role for Nurses as Physician Extenders? Gastroenterology 
Nursing. 2007, 30(1): 45-50 
Sidhu R, Sanders DS, Morris AJ, McAlindon ME, Guidelines on small bowel enteroscopy and 
capsule endoscopy in adults. Gut 2008;57:125–136 
Signorelli C, Villa F, Rondonotti E, et al. Sensitivity and specificity of the suspected blood 
identification system in videocapsule endoscopy. Endoscopy 2005;37:1170-3  
Solem CA, Loftus EV Jr, Fletcher JG et al. Small-bowel imaging in Crohnʼs disease: a 
prospective, blinded, 4-way comparison trial. Gastrointest Endosc 2008; 68: 255–266 
Souquet JC, Bellecoste M, Belbouab S, et al. Prospective evaluation of the automatic 
localization system of the videocapsule during small intestine exploration [abstract]. 
4th International Conference on Capsule Endoscopy, March 7-8, 2005. Program and 
Abstracts. 2005. Program and Abstracts. p. 237 
Swain CP, Gong F, Mills TN. Wireless transmission of a color television moving image from 
the stomach using a miniature CCD camera, light source and microwave transmitter 
[abstract]. Gut 1996;39:A26 
Swain P. Wireless capsule endoscopy. Gut 2003; 52:4:48–50 
Toth E, Fork F, Almquist P, et al. Should capsule endoscopy be the first line imaging 
examination in patients with suspected small bowel Crohn’s disease ? (abstract) 
International Conference on Capsule Endoscopy Miami 2004 
Triantafyllou K.  Can we improve the diagnostic yield of small bowel videocapsule 
endoscopy? World J Gastrointest Endosc 2010 May 16; 2(5): 143-146.  
Triester SL, Leighton JA, Leontiadis GI et al. A meta-analysis of the yield of capsule endoscopy 
compared to other diagnostic modalities in patients with obscure gastrointestinal 
bleeding. Am J Gastroenterol 2005; 100: 2407–2418  
Triester SL, Leighton JA, Leontiadis GI et al. A meta-analysis of the yield of capsule endoscopy 
compared to other diagnostic modalities in patients with non-stricturing small bowel 
Crohnʼs disease. Am J Gastroenterol 2006; 101: 954–964 
Urbain D, De Looze D, Demedts I et al. Video capsule endoscopy in small-bowel malignancy: 
a multicenter Belgian study. Endoscopy 2006; 38: 408–411 
Van Gossum A, Hittelet A, Schmit A, Francois E, Deviere J. A prospective comparative study 
of push and wireless-capsule enteroscopy in patients with obscure digestive bleeding. 
Acta Gastroenterol Belg 2003;66:199–205. 
Vere C., F. Sima, F. ĥapu, T. Ciurea. Videocapsula endoscopică şi enteroscopia cu balon, 
metode moderne de explorare a intestinului subĦire. Craiova Medicală, Vol 10, Nr 1, 
2008, 57-63 
Viazis N, Sgouros S, Papaxoinis K, et al. Bowel preparation increases the diagnostic yield of 
capsule endoscopy: a prospective, randomized, controlled study. Gastrointest Endosc 
2004;60:534–538 
Westerhof J, J J Koornstra, RK Weersma. Can we reduce capsule endoscopy reading times? 
Gastrointest Endosc 2009; 69(3): 497-502 
www.intechopen.com
New Techniques in Gastrointestinal Endoscopy
Edited by Prof. Oliviu Pascu
ISBN 978-953-307-777-2
Hard cover, 310 pages
Publisher InTech
Published online 30, September, 2011
Published in print edition September, 2011
InTech Europe
University Campus STeP Ri 
Slavka Krautzeka 83/A 
51000 Rijeka, Croatia 
Phone: +385 (51) 770 447 
Fax: +385 (51) 686 166
www.intechopen.com
InTech China
Unit 405, Office Block, Hotel Equatorial Shanghai 
No.65, Yan An Road (West), Shanghai, 200040, China 
Phone: +86-21-62489820 
Fax: +86-21-62489821
As result of progress, endoscopy has became more complex, using more sophisticated devices and has
claimed a special form. In this moment, the gastroenterologist performing endoscopy has to be an expert in
macroscopic view of the lesions in the gut, with good skills for using standard endoscopes, with good
experience in ultrasound (for performing endoscopic ultrasound), with pathology experience for confocal
examination. It is compulsory to get experience and to have patience and attention for the follow-up of
thousands of images transmitted during capsule endoscopy or to have knowledge in physics necessary for
autofluorescence imaging endoscopy. Therefore, the idea of an endoscopist has changed. Examinations
mentioned need a special formation, a superior level of instruction, accessible to those who have already
gained enough experience in basic diagnostic endoscopy. This is the reason for what these new issues of
endoscopy are presented in this book of New techniques in Gastrointestinal Endoscopy.
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